Articles By Rachel Tate, DO
Sick Leave in axSpA: Who takes more?
By Rachel Tate, DO
07 November 2021
Who wouldn't like to predict the future?
Read Article
Polyautoimmunity: axSpA and Familial Mediterranean Fever
By Rachel Tate, DO
05 November 2021
Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of Familial Mediterranean Fever (FMF) and axial spondyloarthritis (axSpA), remains rare. In fact, we believe the rate to be between 0.5% and 7.5%.
Read Article
Three Healthcare Hashtags You Should Follow
By Rachel Tate, DO
14 September 2021
I've sent more than 2,000 tweets since joining Twitter in July 2010. Even better, I've read (and sometimes shared) thousands of other educational, informative and sometimes humorous tweets from fellow rheumatologists, physicians, healthcare providers and others around the world. While following individuals and organizations relevant to you is important, so is following hashtags. Here are three I recommend.
Read Article
ICYMI: New GRAPPA 2021 PsO and PsA Treatment Recommendations
By Rachel Tate, DO
07 July 2021
The evidence-based recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis were presented at #EULAR2021. The goal (as per 2009 recommendations) was “To develop recommendations, based upon the best scientific evidence, for the optimal treatment of patients with PsA” Dr. Laura Coates, Oxford detailed in abstract #OP0229. Since the last update in 2015, there have been multiple changes, which are highlighted here.
Read Article
Q-DAPSA for Measuring Disease Activity in PsA
By Rachel Tate, DO
10 June 2021
Given its multiple domains, there remains much discussion over the best disease activity scoring method in PsA. The proverbial "holy grail" would be a measure that is quick, intuitive, domain comprehensive and validated.
Read ArticleNew GRAPPA 2021 PsO and PsA Treatment Recommendations
By Rachel Tate, DO
04 June 2021
The evidence-based recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis were presented at #EULAR2021.
Read Article
HLA B27 Iritis - RNL 2021 Highlights
By Rachel Tate, DO
31 March 2021
The Spondyloarthritis Advances pod presented during the RheumNow Live 2021 conference featured three speakers, including an excellent lecture by Dr. Robert Wang, ophthalmology, on HLA B27 iritis and practical tips for rheumatologists.
Read Article
RWCS Highlights - Day 4
By Rachel Tate, DO
16 February 2021
As another year at RWCS in Maui wrapped up, I’m so thankful I had the opportunity to participate remotely. Here are my day 4 #RWCS2021 pearls from the Novel Therapies Year in Review (RA, SLE, OA); novel concepts in pediatric rheumatology; and post-COVID telerheumatology sessions.
Read Article
RWCS Highlights - Day 3
By Rachel Tate, DO
15 February 2021
Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.
Read Article
RWCS Highlights - Day 2
By Rachel Tate, DO
12 February 2021
As I attend RWCS virtually, I am always amazed by the amount of thought that goes into preparing great talks geared toward busy clinicians. Today, I am highlighting a few more pearls that you may find interesting as well.
Read Article